Omeprazol Tecnigen (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Tecnigen, is a Proton Pump Inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to manage gastro‑reflux related conditions in adults and children. GNH USA supplies Omeprazol Tecnigen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazol Tecnigen is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates. - NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term non‑steroidal anti‑inflammatory drugs.

Omeprazol Tecnigen may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild, often resolves without intervention. - Diarrhea: loose stools that usually improve with continued therapy. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the stomach region. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Hypomagnesemia: low serum magnesium that may cause muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: rare skin reaction with blistering and mucosal involvement. - Liver enzyme elevation: increased ALT/AST indicating hepatic stress. - Anaphylaxis: immediate hypersensitivity reaction with airway compromise.

When prescribing Omeprazol Tecnigen, clinicians should consider several safety aspects: - Assess renal function: adjust use in patients with severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term use: prolonged therapy has been linked to vitamin B12 deficiency and bone density loss. - Evaluate pregnancy status: weigh benefits against potential risks. - Counsel on over‑the‑counter use: avoid duplicate acid‑suppression therapy. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines. Awareness of these interactions helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity, increasing cardiovascular event risk. - Atazanavir: markedly decreased antiviral concentrations, compromising HIV treatment. - Methotrexate (high dose): increased systemic exposure, raising toxicity potential.

Moderate Interactions (Monitor Closely): - Warfarin: possible enhancement of anticoagulant effect, requiring INR monitoring. - Digoxin: altered absorption may change serum levels. - Diazepam: increased plasma concentrations, potentially causing sedation.